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Abstract
Identifying the nodes that have the potential to influence the state of a network is a relevant
question for many complex interconnected systems.
Despite recent advances in network controllability, the univocal identification of the driver
nodes remains difficult in practice because of the combinatorial and numerical complexity
associated with existence of a huge number of equivalent controllable walks, even in relatively
small networks. However, in many applications it is often essential to test the ability of an
individual node to control a specific target subset of the network. In biological networks, this
might provide precious information on how single genes regulate the expression of specific
groups of molecules in the cell.
Taking into account these constraints, we propose an optimized heuristic based on the
Kalman rank condition to quantify the centrality of a node as the number of target nodes it
can control. By introducing a hierarchy among the nodes in the target set, and performing a
step-wise research, we ensure for sparse and directed networks the identification of a controllable
driver-target configuration in a significantly reduced space and time complexity.
We show how the method works for simple network configurations, then we use it to
characterize the inflammatory pathways in molecular gene networks associated with macrophage
dysfunction in patients with multiple sclerosis. Results indicate that the targeted secreted
molecules can in general be controlled by a large number of driver nodes (51%) involved in
different cell functions, i.e. sensing, signaling and transcription.
However, during the inflammatory response only a moderate fraction of all the possible
driver-target pairs are significantly coactivated, as measured by gene expression data obtained
from human blood samples. Notably, they differ between multiple sclerosis patients and healthy
controls, and we find that this is related to the presence of dysregulated genes along the
controllable walks.
Our method, that we name step-wise target controllability, represents a practical solution to
identify controllable driver-target configurations in directed complex networks and test their
relevance from a functional perspective.
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1 Introduction
For many biological systems, it is crucial to identify the units, such as genes or neurons,
with the potential to influence the rest of the network, as this identification can enable
describing, understanding, and eventually controlling the function of the system [1,2].
Topological descriptors based on network science can indeed be used to quantify such
influence in terms of node centrality, such as degree, betweenness, or closeness [3].
However, these descriptors only capture the structural properties of the network and
neglect their effect on the dynamics, thus limiting our understanding on the actual
influencing power.
Control network theory, linking network structure to dynamics through linear or
nonlinear models, has been shown to be a more principled approach for identifying driver
nodes in an interconnected system [4,5]. While theoretically these approaches can give
a minimum set of driver nodes sufficient to steer the system into desired states, their
exhaustive identification might be difficult in practice as there exists in general a very
large number of equivalent controllable walks, even in relatively simple networks [6,7].
In the case of criteria based on the manipulation of controllability matrices [8, 9], the
presence of many walks can for example induce numerical errors due to the different
orders of magnitude in the matrix elements.
An alternative solution has recently been proposed to circumvent this limitation,
based on the possibility to map the controllability problem onto the maximum cardinality
matching over the associated graph [10–12]. As a result, it is possible to identify a set
of driver nodes - at least for directed networks - with linear, and not exponential, time
complexity [13]. While this approach elegantly solves numerical issues, it can nevertheless
not tell which configuration, among all the possible ones, is the most relevant. In general,
there is a factorial number of equivalent configurations (with the same number of inputs)
and enumerating all possible matchings [14] rapidly becomes unfeasible, even for simple
graphs such as trees [6, 7], bipartite graphs [15], or random graphs [16]. Thus, the
research of alternative strategies to characterize the candidate driver nodes is crucial for
the concrete application of network controllability tools.
One possibility would be to reduce the original problem into smaller sub-problems
under the assumption of specific constraints compatible with the underlying scientific
question. On the one hand, for many biological, technological and social systems it
is desirable to only control a subset of target nodes (or a subsystem) that is essential
for the system’s mission pertaining to a selected task or function. In this direction
some approaches have been recently proposed, based on filtering of the controllability
matrix [17] or adaptation of graph matching [18–21]. However, they do not solve
the problem of multiple driver set configurations. On the other hand, technical and
experimental constraints often limit the possibility to stimulate many driver nodes in
parallel, for example in gene expression modulation [22] or brain stimulation [23]. In
these cases, approaches that focus on the ability of single driver node to control the entire
network, such as control centrality [24] or single-node controllability [25], do circumvent
the multiplicity issue, but can still suffer from numerical errors and approximate results.
To overcome this impasse, we propose an integrated method that combines the
advantages of the previous approaches and quantifies the capacity of a single driver node
to control a predefined target set. Based on the Kalman controllability condition, our
method identifies the part of the target set that can be controlled by a candidate driver.
To do so, we introduce a ranking among the target nodes and we iteratively evaluate the
controllability of the system by adding one target node at a time in a descending order.
This eventually finds a univocal controllable configuration corresponding to the highest
ranking. In the following, we first illustrate how our method, named step-wise target
controllability, works for simple network structures and we discuss the potential benefits
for directed and sparse networks, in terms of space and computational complexity, as
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compared to alternative approaches. Then, we use it to study molecular networks of
macrophage pro-inflammatory activation, derived from ontology-based reconstructions,
and identify the driver-target pathway alterations using gene expression data from blood
samples of patients affected by multiple sclerosis (MS) and a matched group of healthy
controls (HC).
2 Results
Step-wise target controllability identifies a controllable subset of
targets
Let G be a directed graph (or network) of N nodes (or vertices) and L links (or edges), and
T an arbitrary subset of S < N nodes in the network. The aim is to measure the ability
of each node to drive the state of the target set T from a dynamical system perspective [5].
In the case of linear time-invariant dynamics, the number of controllable target nodes
can be obtained computing the rank of the target controllability matrix [18,26,27]:
QT =
[
CB CAB CA2B · · · CAN−1B] (1)
where A is the adjacency matrix of the network, B is a vector identifying the driver
node and C is a matrix selecting the rows of A corresponding to the target, or output,
nodes (Material and methods).
A walk in the network consists of an alternating sequence of vertices and edges.
The (i, j) entry of QT indicates how many walks of length j− 1 connect the driver to
the target i [28]. Trivially, all the nodes not traversed by these walks do not contribute
to the walk lengths and they can be neglected for the purpose of control. By removing
the irrelevant nodes from the network, A becomes smaller and this results in a target
controllability matrix with less columns. Put differently, we avoid the computation of
matrix exponentials corresponding to non-existing driver-target walks (Material and
methods). In practice, this can be of great advantage for reducing the occurrence of
round-off errors during the matrix rank calculations. For example, this is the case for
sparse and directed networks, where fewer nodes are reachable as compared to dense
and undirected networks.
This can be easily appreciated in the following example. Let us consider a directed
full binary tree with h = 6 levels, with the root node as the candidate driver. Without
loss of generality, we randomly position a target in each level and we rank them according
to their height in the tree. Then, we introduce a simple cycle among the first three
nodes of the tree (Fig. S1). By construction, this configuration is controllable and the
entire target set can be fully driven by the driver. However, when considering the entire
network the returned rank is deficient. Instead, by removing the part of the network
that is irrelevant for the control, the rank is full and we retrieve the entire controllable
configuration, even in the case of larger networks, i.e. up to h = 10 levels.
The rank of QT gives the number of target nodes τ ≤ S controllable by the driver,
but there might be in general many possible equivalent configurations. To overcome this
issue, we propose a step-wise procedure that tests the controllability on subproblems of
increasing size. First, we introduce a hierarchy among the target nodes and relabel them
according to their importance in a descending order, i.e. t1  t2  ...  tS . Then, we
create an empty auxiliary set T ′ and we sequentially include the target nodes according
to their ordering. At each step, if the rank of QT ′ is full, the new target node is retained,
otherwise it is removed from T ′. When all the target nodes have been visited, the
algorithm returns the set of controllable targets with highest ranking (Fig. 1, Material
and methods).
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Our method, named step-wise target controllability, not only returns for each candidate
driver the number of controllable target nodes τ corresponding to the configuration with
highest ranking, but also the set T ′ of controllable targets.
Driver genes are homogeneously distributed in the macrophage
network
To test our method in a biological context, we construct a network representing the
interactions between molecules involved in macrophages response to pro-inflammatory
stimuli (Fig. 2), with the connections between genes inferred from a previously estab-
lished network based on literature [29, 30]. This network is of interest in MS due to the
chronic inflammation characteristic of the disease, and the generally destructive effects
of pro-inflammatory macrophages in MS [31]. Hence, dysregulation of macrophages may
lead to aggravated inflammation and disease.
In order to facilitate biological interpretation of the network, we divide the nodes
according to molecular function: sensing, signaling, transcription factors or secreted
molecules (Tab. S1). We choose the 13 secreted molecules as target nodes because
they represent the end-products of macrophage pro-inflammatory activation and enable
propagation of inflammation to other cells, thus exacerbating chronic inflammation.
To establish a hierarchy among the targets, we use macrophage RNA expression data
from a group of MS patients and healthy controls. The macrophages were tested with
and without activating stimuli to mimic the pro-inflammatory response. We measure
the gene activation as the ratio of the expression between the “pro-inflammatory” and
“alert” condition. We then consider the fold change ∆ between the gene activation of MS
patients and HC subjects (Material and methods). Genes with larger ∆ values are
ranked first (Fig. S2).
Results show that 51% of the tested network nodes can control at least one target
(i.e. τ > 0) and that those drivers tend to be homogeneously distributed across classes
(Tab. S2). This indicates a high redundancy in the way the target set can be controlled.
Notably, target centrality values are weakly correlated (Spearman rho 0.18, p < 0.07)
with the corresponding total node degree k, as defined in Material and methods,
indicating that the most connected genes (e.g. RELA, NFKB1) are not necessarily the
ones that can most efficiently steer the state of the target set (Fig. 3a).
Almost all of the driver nodes identified by our method can control the target genes
CCL5, CXCL10, CXCL11, IFNA1 and IFNB1, which code for inflammatory chemokines
and cytokines. This implies a high level of co-regulation among these molecules, with
many different actors exerting control over this regulation. Interestingly, the drivers
with the highest target control centrality values (SOCS1 and SOCS3, τ = 10) belong
to feedback systems that control pro- and anti-inflammatory signal transduction by
regulating the signaling process triggered in response to IFNγ [32]. In addition, all
drivers with τ > 9 can be seen in our network as a cluster of genes converging onto
and including STAT1 (Fig. 3a). This cluster includes the receptors of IFNγ and the
signaling molecules responsible for their intracellular effects. This result matches the
well-described effects of IFNγ on chemokine production [33, 34] and overall macrophage
activation [35].
Robustness of driver nodes to random attacks
To assess the stability of our findings to possible errors in the network construction, we
performed a robustness analysis simulating different types of alterations to its nodes
and links (Material and methods). Results show that removing nodes with higher
degree k leads to a greater reduction of control centrality in the drivers compared to
the removal of low-degree nodes or random removal of nodes (Fig. 3b). For example,
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by attacking 10% of the nodes we lose 5% of the drivers in the latter cases, while we
lose 20% of the drivers when removing the most connected ones (Fig. 3b). This result
confirms the crucial role of hubs in biological networks in terms of resilience to random
attacks [36] and controllability [37].
When perturbing links, the worst condition is given by their random removal. By
attacking 10% of the links around 5% of the drivers are lost. This is intuitively due to
the interruption of driver-target walks and to consequent impossibility to control a node
that cannot be reached. While randomly rewiring the links has an intermediate impact,
adding new links has no effect on the target control centrality of the drivers (Fig. 3c).
This is of great advantage as it shows that our results will not change if new connections
are established or provided by the literature.
Gene dysregulation and altered driver-target coactivation in mul-
tiple sclerosis
Using step-wise target controllability, we detect potential directed interactions in the
macrophage activation network, but we cannot quantify how changes in the driver’s state
affect those in the targets. To measure driver-target functional interactions, we compute
the Spearman correlation between the gene activation of controllable driver-target pairs,
for the HC and MS groups (Material and methods, Tab. S3). We call coactivated
the genes exhibiting a significant correlation (p< 0.05). Results show that in general
only a moderate fraction (21%) of all the possible driver-target genes are coactivated
(Fig. 4a, Tab. S3). For both HC and MS groups these interactions tend to primarily
involve signaling functions Fig. 4b. However, the number of driver-target coactivations
is lower in the pathological condition (MS = 19 versus HC = 36). More importantly,
they differ from those observed in the HC group (Fig. 4b). This is particularly evident
for target IFNA1, which only exhibits coactivations with signaling and transcription
drivers in the MS group (Fig. 4c).
Because the macrophage network edges are fixed and reconstructed from known
protein-protein interactions, differences in coactivation can be essentially attributed
to altered regulation of transcription. Hence, our hypothesis is that the observed
functional reorganization can be explained by the dysregulation of specific genes along
the controllable walks from the drivers to targets. To test this prediction, we examine
all the pairs of genes whose coactivation appears or disappears in the MS group (Fig.
4a). We found that 47/51 of these differentially coactivated pairs present at least
one dysregulated gene (i.e., fold change |∆| above the 75-percentile, Material and
methods) on the walk from the driver to the target (Fig. 5, Tab. S4).
We find in total 14 dysregulated nodes on any of these walks. The genes that most
frequently appear are NFKB1, IFNA1 and IFNB1 (36/51 walks). They are present on
all walks that end with targets CCL5, CXCL10, CXCL11, IFNA1 or IFNB1, i.e., the
5 targets that could be controlled by most drivers. This points to their dysregulation
being a potent disruptor of the normal network functioning. The co-occurrence of
these three dysregulated genes can be explained by a feedback loop in which NFKB1
activates IFNB1, and IFNA1 and IFBN1 both activate STAT2, which through several
intermediates can influence all three genes (Fig. S3). Indeed, this stems from the fact
that all these nodes belong to the main connected component of the network, i.e. a
subnetwork in which every node is reachable from any other node.
Taken together, these results indicate that the aberrant reorganization of functional
interactions in the MS group is associated with the presence of dysregulated genes along
the controllable walks of the macrophage network.
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Switch of SOCS-gene coactive drivers reflects dysregulated inflammatory
response
Because drivers are crucial for steering the target network’s state, we focus on the
subnetwork specifically involving the dysregulated drivers (IRF8, NFKB1, SOCS1,
SOCS3, TLR7) and the walks towards the respective controllable targets Fig. 6. By
looking at how driver and target nodes are differently coactivated in healthy controls
and MS patients, we obtain a much clearer description of the gene dysregulation effects.
First, many of the previous results can be now appreciated in finer detail, such as i) the
reduction in number of coactivated driver-target pairs in MS, ii) the large number of
targets that can be controlled by SOCS1 and SOCS3, and iii) the potential of NFKB1,
IFNA1 and IFNB1 to affect the driver-target functional interactions.
Second, we report an interesting mechanism involving the drivers with the highest
τ centrality values, i.e. SOCS1 and SOCS3. In the HC group, SOCS1 is coactivated
with the targets while SOCS3 does not exhibit any significant correlation. In the MS
group, we observe the opposite, i.e. SOCS1 is silent while SOCS3 becomes coactive.
Because both driver genes are dysregulated, the observed “switch” mechanism could
be therefore associated with the altered pro-inflammatory response of the MS group.
Indeed, these two molecules are known to be strong modulators of macrophage response:
SOCS1 inhibits the signaling of pro-inflammatory genes while SOCS3 is known to be an
important actor in inflammatory response, with the ratio of the two proteins determining
the actual effect [38].
3 Discussion
Identification of controllable configurations in complex networks
Network controllability refers to the ability to drive an interconnected dynamical system
from any initial state to any desired final state in finite time, through a suitable selection
of inputs [4, 5]. In recent years, an increasing number of research groups from different
disciplines have focused their efforts on identifying the minimum set of driver nodes or
quantifying the capacity of single nodes to control the entire network, as well as parts
of it [39–49]. Despite being theoretically attractive, network controllability still suffers
from computational issues that limit its impact in concrete applications. This is mainly
due to the presence of multiple equivalent controllable walks in a network that make
the associated controllability problem ill-posed and/or the resulting solution space very
big [4, 5].
To reduce such complexity, we propose a method based on control centrality, which was
previously designed to quantify the ability of one node to control directed networks [24].
First, we define the target control centrality to measure the controllability of a specific
part of the network, i.e., a predefined target set. Because edges are directed, this has the
advantage to ignore the part of the network that is not traversed by the walks connecting
the driver to the target set. Second, we introduce an ordering among the target nodes
and perform a step-wise controllability test with increasing size. Because of the ranking,
only one controllable configuration will be identified, i.e. the one with the highest ranking
(Fig. 1). To test the controllability of the driver-targets configuration at each step we
adopted the Kalman criterion [4, 8]. However, the entire iterative framework is quite
flexible and other methods, such as Gramian condition [50], Popov-Belevich-Hautus
criterion [21], or feedback vertex set [51], could be used as alternative controllability
criteria.
While the step-wise target controllability achieves the identification of one solution
in a significantly reduced amount of time, it is important to state that the method for
ordering of the targets is a subjective choice. For example, targets can be sorted according
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to their importance in a biological function (e.g. genes) [52, 53] or in discriminating
pathological conditions (e.g. brain areas) [54,55]. The choice of sorting criteria should
reflect the specific scientific question. In a more network-centric approach, ordering could
rely on the ranking of topological network properties such as node centrality measures [3].
While this is beyond the scope of our study, we feel that this should be more extensively
investigated by future research.
Control pathways in macrophage molecular networks
The study of the molecular interactions is crucial to the understanding of the basic
functions of the cell such as proliferation or apoptosis [56,57]. Determining the connection
mechanisms that rule a specific biological function can significantly impact our daily
life by providing new therapeutics to counteract diseases [58–60]. Studying molecular
networks is however difficult, because in general we do not know the true functional
interactions of a cell and indirect techniques such as gene co-expression are typically
employed to infer such connections [61]. Based on correlation analysis, these methods
cannot inform on the causal nature of the interactions. More importantly, the reliability
of the estimated network critically depends on the number of interactions to number of
data samples ratio, which is in practice very low [61].
To overcome this limitation, we reconstruct the directed gene interactions associated
with the inflammatory state of the human macrophages by adopting a novel ontology-
based approach that integrates the available information from multiple datasets and
results in the literature [62]. Previous studies show that the number of driver nodes in
biological networks is rather high due to their sparse and heterogeneous nature [12,63].
Consistently, we find that a large percentage of genes (51%) can control at least one
secreted molecule in the target set. Our results also confirm that, despite being crucial
for global communication, hubs (e.g. RELA) are not always the most important from a
network control perspective (Fig. 3a). This stems from the theoretical impossibility
to diversify the input signals to all the connected neighbors [12]. The found driver
genes are heterogeneously distributed across the tested gene classes. However, our
method highlights SOCS1 and SOCS3 as the drivers with the highest target control
centrality values, with other IFNγ-response-related genes showing similar values. This
is in line with the known effects of SOCS-genes and IFNγ on molecules secreted by
pro-inflammatory macrophages [32–35], supporting the ability of this method to identify
biologically relevant drivers.
Overall, these results uncover the existence of potential causal influences from can-
didate driver genes to the secreted molecules in the human macrophage activation
network. Because the identified driver nodes are robust to network alterations, notably
when adding new links (Fig. 3c), the obtained results are expected to be sufficiently
resilient to the integration of new gene-gene interactions. From a different angle, our
approach can be seen as a new way to filter information in complex networks and
focus on the specific nodes (the drivers) or node pairs (driver-target). This might have
important consequences when studying genome-wide databases where the high number
of elements can make prohibitive the assessment of significant gene expressions and/or
co-expressions [64,65].
Dysregulated genes and aberrant interactions in multiple sclero-
sis
Multiple sclerosis is an immune-mediated disease in which the immune system erroneously
attacks myelin in the central nervous system. There are many neurological symptoms,
including motor and cognitive deficits, that can vary in type and severity depending
on the attacked central nervous system regions [66]. The role of macrophages in
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MS is crucial because of their ability to obtain a pro-inflammatory activation state,
including the release of pro-inflammatory cytokines and leading to central nervous system
tissue damage [67]. Hence, dysregulation of macrophages may lead to autoimmunity
and persistent inflammatory diseases [68]. While the etiology of MS is still not well-
understood there is a large consensus on its genetic basis and on the importance of
unveiling the underlying network mechanisms [69].
In this study, we combined network controllability tools and gene expression data to
detect the genes responsible for altering the macrophages action in multiple sclerosis.
Differently from standard approaches, where the attention is focused on the identification
of the driver nodes in a network, we here propose an alternative way of exploiting network
controllability. We first show that the macrophage inflammatory state in the MS group
was characterized by a drastic alteration of the coactivations in the driver and target
genes (Fig. 4). Such absence of coordination was in general associated with the presence
of dysregulated genes along the walks from the driver to the target node. Notably, the
pathological dysregulation of NFKB1, IFNB1 and IFNA1, which belong to the same
feedback cycle (Fig. S3), critically affects several driver-target functional interactions
(Fig. 5).
Finally, our approach allows to identify a shift mechanism for dysregulated SOCS1 and
SOCS3 drivers, showing opposite coactivation patterns in MS patients compared to the
healthy controls (Fig. 6). These results suggest that experimentally stimulating SOCS3
- a strong inducer of pro-inflammatory response - might be more effective for moving
the state of the altered secreted molecules towards physiological configurations. Taken
together, these results might have practical consequences on how to design intervention
strategies and counteract disease phenotype.
Methodological considerations
Our method uses Kalman controllability rank condition [8] to quantify the centrality
of the driver nodes. This criterion assumes that the investigated system has a linear
dynamics, Eq. 2. In our case, this means that the changes in the gene activation would
follow a linear trend. While this is in general not true and difficult to ascertain, it appears
that results from non-linear tests are often dominated by linear relationships [70, 71].
Furthermore, a significant fraction of the data analysis and modeling deals exclusively
with linear approaches as they are simpler, easy to interpret and serve as a prerequisite
of nonlinear behavior [39].
Another peculiarity of our approach is the assumption of time-invariant interactions
in the molecular gene network. On the one hand, this assumption allows to better
exploit the well-established results and tools in network controllability [12]; on the other
hand, it might conflict with existing literature looking for biological connectivity changes
between conditions or populations such as differential gene coexpression [72]. Here,
we hypothesized that the activation state of each node (in terms of gene expression)
could eventually change but not the underlying network structure. Thus, our network -
obtained from detailed maps of the macrophage cells - would only act as a substrate/proxy
for functional interactions, such as correlated gene activities.
The implementation of our algorithm does not account for the case in which the
ordering of the targets is not unique, two nodes having the same importance. One
possible solution may be to add equally important targets at the same iteration step
(that is together instead of one at a time) and test if they can be controlled together.
This may not be ideal, because the algorithm will consider them controllable only if
both of them can be controlled, still it avoids the combinatorial problems linked with
testing multiple targets. However, in many biological contexts such as the one we used,
the ordering is based on continuous values and will in general be unique.
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We finally notice that our method is conceived for directed networks only, where
the dimensionality reduction has a real computational benefit. In fact, in the case of
undirected graphs, it is not possible to remove nodes on the walks from the driver to the
targets since information is bound to span the entire network. Similarly, for directed
but dense networks, the possibility to focus on specific parts of the network, and reduce
the computational cost, becomes lower regardless of the topology.
To conclude, it is important to mention that extensions of network controllability
tools to time-varying frameworks do exist [73,74]. However, in that case networks would
be inferred from gene coexpression and therefore affected by statistical uncertainty due
to sample sizes. Further research is needed to seek how to apply network controllability
in presence of noisy time-varying connections.
Conclusion
In this study, We introduce a method to quantify the ability of candidate driver nodes
to drive the state of a target set within a sparse and directed network. Further, we
illustrate how this method works for the molecular network associated with the human
macrophage inflammatory response. The obtained results reveal in a principled way
the genes that are significantly dysregulated in multiple sclerosis. We hope that this
method can contribute to the identification of the key nodes in biological networks to
better identify pharmacological targets to counteract human diseases.
4 Material and methods
Step-wise target controllability
We introduce a method to identify which target nodes in a network that can be controlled
from a single driver node. To do so, we start by considering the canonical linear time-
invariant dynamics on a directed network described by the adjacency matrix A ∈ RN×N
x˙(n) = Ax(n) +Bu(n), y(n) = Cx(n) (2)
where x(n) ∈ RN describes the state of each node at time t, B ∈ RN specifies the
driver node, u(n) ∈ RN is its external input (or control) signal, y(n) ∈ RS is the output
vector, and C ∈ RS×N is the output matrix identifying the target nodes.
Such a system is controllable if it can be guided from any initial state to any desired
final state in finite time, with a suitable choice of input. A necessary and sufficient
condition to assess the controllability of Eq. 2, is that the controllability matrix Q
Q =
[
B AB A2B · · · AN−1B] (3)
has full row rank, i.e. rank(Q) = N . That is the Kalman rank condition, which
basically verifies the existence of linearly independent rows in Q [4, 8]. If so, the driver
node can reach and control the dynamics of all the other nodes through independent
walks of length N − 1 at maximum.
If it is of interest to control only a target set T of the network, specified in C and
consisting of S ≤ N nodes, then Eq. 2 can be reduced into a target controllability
matrix QT = CQ (Eq. 1), where C filters the rows of interest corresponding to the
targets. Now, the rank of QT gives the number τ ≤ S of nodes in the target set that
can be controlled by the driver.
To identify a driver-target configuration, we further introduce a hierarchy among the
target nodes, so that we can order and relabel them from the most important one to the
least, i.e. t1  t2  ...  tS . Then we perform the following step-wise procedure for each
candidate driver node
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• Step 1. Initialization
– Create a temporary empty target set T ′ ← {}
– Set the number of controllable targets τ ← 0
• Step 2. Repeat until termination criteria are met. For j ← 1, ..., S do
– Add the j-th target node to the target set T ′ ← T ′ ∪ {tj}
– Build the subgraph containing the nodes on walks from the driver to the
targets in T ′
– Compute the rank of the target controllability matrix QT ′
– If rank(QT ′) is full then τ ← τ + 1 else T ′ ← T ′ \ {tj}
– j ← j + 1
• Step 3. Output τ and T ′
Eventually, the target control centrality τ is the number of controllable targets in T ,
and the set T ′ contains the τ controllable targets with highest ranking.
Construction of the macrophage activation network
We reconstruct the inflammatory molecular network of the human macrophage by
integrating information from the macrophage signal transduction map [29, 30]. This
map contains a comprehensive, validated, and annotated map of signal transduction
pathways of inflammatory processes in macrophages based on the current literature. To
extract molecular interactions from this map, we used the Hermit software [75], which
implements automatic reasoning based on logical rules. We specifically used the rules
implemented in the molecular network ontology to infer molecular interactions depending
on the process they belong [62, 76]. Because we are interested in the inflammation
process, we restricted our analysis to a specific subset of 101 genes with known roles
in macrophage pro-inflammatory activation, and for which their regulation in response
to pro-inflammatory stimuli could be confirmed in our data set. These genes were
classified according to their function in the cell: sensing, signaling, transcription and
secreted (Tab. S1), as described in databases such as NCBI Gene [77], UniProt [78]
and GeneCards [79]. The full network was thus reduced to only include these genes
and their interactions. Due to recent studies, we also opted to exclude two edges (from
SOCS3 to IFNGR1 and to IFNGR2) to represent the involved pathways [38].
The resulting network contains N = 101 nodes and L = 211 unweighted directed
edges representing either activation or inhibition between genes. The total degree k of
each node in the network is computed by summing the number of incoming and outgoing
edges:
ki =
N∑
j=1
Aij +
N∑
j=1
Aji (4)
where Aij = 1 if there is an edge between the corresponding genes, and 0 otherwise.
Collection of macrophage mRNA expression data
Collection of blood for the study was approved by the French Ethics committee and
the French ministry of research (DC-2012-1535 and AC-2012-1536). Written informed
consent was obtained from all study participants. All patients fulfilled diagnostic criteria
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for multiple sclerosis [80], and individuals (multiple sclerosis patients and healthy donors)
with any other inflammatory or neurological disorders were excluded from the study.
Patients were included in the study only if they were not undergoing treatment.
Blood was sampled from 8 MS patients and 8 healthy controls in acid citrate dextrose
tubes. From blood samples, peripheral blood mononuclear cells were isolated using Ficoll
Paque Plus (www.gelifesciences.com) and centrifugation (2200 rpm, 20 min). Cells
were washed in PBS and RPMI +10% FCS. Monocytes were isolated with anti-CD14
microbeads (www.miltenyibiotec.com) and plated in 12-well plates (500000 cells/well)
in RPMI +10% FCS and granulocyte-macrophage colony-stimulating factor (500 U/ml)
to induce differentiation into macrophages. After 72h, media was replaced with fresh
media supplemented with granulocyte-macrophage colony-stimulating factor (500 U/ml)
to maintain “alert” macrophages or IFNγ (200 U/ml) + upLPS (10 ng/ml) to induce
“pro-inflammatory” activation. Cells were lysed after 24h and RNA was extracted with
RNeasy Mini Kit (www.qiagen.com).
Transcriptome sequencing cDNA libraries were prepared using a stranded mRNA
polyA selection (Truseq stranded mRNA kit, www.illumina.com). For each sample,
we performed 60 million single-end, 75 base reads on a NextSeq 500 sequencer (www.
illumina.com). RNA-Seq data analyses were performed by GenoSplice technology
(www.genosplice.com). Sequencing, data quality, reads repartition (e.g., for potential
ribosomal contamination), and insert size estimation are performed using FastQC [81],
Picard-Tools (http://broadinstitute.github.io/picard/), Samtools [82] and rseqc
[83]. Reads were mapped using STARv2.4.0 [84] on the hg19 Human genome assembly.
Gene expression regulation study was performed [85]. Briefly, for each gene present in
the FAST DB v2018 1 annotations, reads aligning on constitutive regions (that are not
prone to alternative splicing) were counted. Based on these read counts, normalization
was performed using DESeq2 [86] in R (v.3.2.5) [87].
Network modeling and data analysis
In the modeling framework described by Eq 2, matrix A corresponds to the molecular
network and represents the time-invariant component of the system. The dynamic
component is instead represented by the gene activation response in the healthy and
diseased condition (Fig. 2b), computed as the ratio in gene expression between the “pro-
inflammatory” and “alert” condition. Specifically, x(n) represents the gene activation.
B is a vector identifying the candidate driver. The control signal u(n) is out of the scope
of this work. The output vector y(n) and the output matrix C identify the target nodes.
We select the genes belonging to the secreted molecules class (Tab. S1) as our
target set T . All the nodes in the other classes are then tested separately as potential
driver nodes by computing their target control centrality τ . To enhance numerical
precision, the logarithmic transformation log (q + 1) is applied to the elements of the
target controllability matrix QT (Eq. 1).
The hierarchy among the target nodes is established by computing the fold change ∆
between the corresponding gene activation in the two groups:
∆ =
µMS
µHC
(5)
where µMS and µHC are group-averages for MS patients and healthy controls, respectively,
of the gene activation. Nodes with higher ∆ absolute values are ranked first. Highly
positive ∆ values indicate a too strong inflammatory response (over-activation) in the
MS patients with respect to the healthy controls. Highly negative ∆ values indicate a
too weak inflammatory response (under-activation). We define dysregulated genes along
the controllable driver-target walks as those for which |∆| is above the 75th percentile.
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We perform a robustness analysis to evaluate the stability of the identified driver nodes
to potential errors in the molecular network reconstruction. We simulate attacks with
increasing intensity, i.e. up to 20% of the nodes or edges in the network. When removing
nodes, we consider the following cases: i) random deletion, ii) preferential removal of
high-degree nodes, and iii) preferential removal of low-degree nodes. Preferential attacks
are performed by selecting nodes with a probability p proportional to their degree k, i.e.
p ∝ k for high-degree nodes and p ∝ −k for low-degree nodes. When perturbing edges,
we test: i) random addition, ii) random deletion, and iii) random rewiring. For each case,
we simulated 1000 repetitions and we computed the target control centrality τ for the
driver nodes identified in the original network. Then, we report the percentage of nodes
that cease to be drivers (i.e. τ = 0), that is, the percentage of nodes that are drivers in
our analysis, but are no longer able to control any target in the perturbed case.
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Figures
Fig 1. Working principle of step-wise target controllability. Panel a) illustrates a
network with one driver and a target set T = {t1, t2, t3} of cardinality S = 3. The Kalman
condition informs us that only two targets are controllable from the driver, i.e. τ = rank(QT ) = 2.
However, there might be up to 3 equivalent configurations that are controllable, i.e. {t1, t2},
{t1, t3}, and {t2, t3}. For larger networks, the number of Kalman tests to perform can be
prohibitive, i.e.
(
S
τ
)
. Panel b). By introducing a hierarchy among the target nodes, our
step-wise method identifies the configuration with the most important nodes by performing
only S tests (see Material and methods). In this example, the first step considers the
subgraph containing all the walks from the driver to the target set T ′ = {t1}. The associated
controllability matrix has full rank, i.e. rank(QT ′) = 1. The first target is therefore retained
and the algorithm moves to Step 2, by constructing a new subgraph containing the walks from
the driver to the target set T ′ = {t1, t2}. The rank of the new controllability matrix is now
deficient and t2 is not retained. In Step 3, the new subgraph contains the walks from the driver
to T ′ = {t1, t3}. Because rank(QT ′) is full and there are no more targets, the algorithm stops
and returns the controllable configuration t1, t3.
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Fig 2. Molecular network and gene activation associated with the pro-
inflammatory state of macrophages. Panel a) shows the molecular network reconstructed
through ontology-based techniques from the macrophage.com repository [29, 30]. The net-
work consists of N = 101 nodes corresponding to genes involved in inflammation; for the
sake of interpretablity, they are organized in four classes, depending on their function in the
cell. Sensing genes are in the membrane of the cell and start a signaling pathway inside the
cell, to the transcription factors, which promote the production of secreted molecules. There
are L = 211 directed edges representing either activation or inhibition interactions between
molecules (Material and methods). The size of the nodes is proportional to their total
degree k. Panel b) shows gene activation computed as the ratio in expression between the
“pro-inflammatory” and “alert” states, based on our RNA sequencing data, generated from
monocyte-derived macrophages from blood samples of multiple sclerosis patients (n = 8) and
healthy controls (n = 8) (Material and methods). Solid lines represent group-averaged
values, while transparent patches stand for standard deviation.
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Fig 3. Gene network target control centrality and analysis of robustness for the
driver nodes. In panel a) the size of the nodes codes the step-wise target control centrality
values τ . Nodes with τ = 0 are classified as not-drivers and are represented in gray. The inset
shows that τ values cannot be merely predicted by node degree k (Spearman rho 0.18, p < 0.07).
Panel b) shows the percentage of driver nodes (τ > 0) that are lost when removing nodes in
a random fashion (black circles), or preferentially attacking high-degree (blue diamonds) or
low-degree nodes (light blue triangles). Panel c) shows the percentage of driver nodes that are
lost when randomly rewiring (black circles), adding (blue diamonds) or removing edges (light
blue triangles).
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Fig 4. Altered driver-target coactivation in multiple sclerosis. Panel a) reports the
coactive driver-target pairs, computed as significant Spearman correlations (p< 0.05) between
the gene activation of controllable driver-target pairs, for the healthy control (HC - blue squares)
and the multiple sclerosis group (MS - red squares). White squares indicate that there is a
controllable walk from the driver to the target, but that their correlation is not significant. Grey
squares mean that there is no controllable walk for driver-target pairs. The size of the circles
for driver nodes codes for their target control centrality values τ . For target genes, circle sizes
represent the number of driver nodes that can control them. Panel b) Venn diagram showing a
decrease in number of driver-target coactivations in the MS patients as compared to HC. In
both groups, these functional interactions tend to predominantly involve signaling genes. Panel
c) subnetwork of the walks from all the drivers coactivated with the target IFNA1.
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Fig 5. Pooled visualization of dysregulated genes along differentially coactivated
driver-target walks. Highlighted genes indicate all nodes on walks between coactivated driver-
target pairs, either in the healthy control group, or in the MS patients group. Dysregulated
genes are shown in red. Edge thickness is proportional to the number of times they are traversed
by walks connecting a driver to a target node (information not reported here).
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Fig 6. Dyregulated drivers and coactivation switch for SOCS-genes. The subnetwork
includes all dysregulated drivers (IRF8, NFKB1, SOCS1, SOCS3, TLR7) and their controllable
targets. Panel a) shows coactivated pairs for healthy controls (HC), panel b) shows coactivated
pairs for multiple sclerosis (MS) patients. A coactivation switch can be appreciated between
the HC and MS group. SOCS1 and SOCS3 are respectively coactive and silent in HC, while
they invert their role in the MS group.
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Supplementary figures
Fig S1. Methodological validation of step-wise target controllability. We start from
a simple directed full binary tree, and we add a cycle among the first three nodes. The driver
is the root of the tree, while we put a target node in each level of the tree. Target nodes are
then ranked according to their height h. This configuration is fully controllable by construction
regardless of the tree’s height h. However, for h = 5 (i.e. N = 63), the standard procedure
computing the rank of the full Kalman controllability matrix cannot retrieve all the targets, as
the rank computation is deficient due to numerical errors. Instead, by using the step-wise target
controllability we can correctly identify the controllable targets up to h = 10, i.e. N = 2047.
Fig S2. Hierarchy among target genes. Genes corresponding to the 13 secreted molecules
are ranked according to the absolute value of fold change ∆ in the gene activation between the
multiple sclerosis (MS) group and the healthy control (HC) group (Materials and methods).
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Fig S3. Subnetwork illustrating the feedback cycle between dysregulated genes
IFNA1, IFNB1 and NFKB1. The three nodes belong to the only strongly connected
component (a subnetwork in which every node is reachable from any other node) of the network
having more than two nodes. It plays, thus, a central role in the network topology.
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